Goodrx Holdings 

Yahoo Finance • 11 months ago

The GoodRx Effect: Delivering a Transformative Impact on the U.S. Healthcare System through Prescription Savings

New report reveals that by improving medication access and adherence, GoodRx has helped save Americans $65 billion and the healthcare system over $5 billion SANTA MONICA, Calif., January 11, 2024--(BUSINESS WIRE)--GoodRx (NASDAQ: GDRX), t... Full story

Yahoo Finance • last year

GoodRx Holdings, Inc. (NASDAQ:GDRX) Shares Could Be 42% Below Their Intrinsic Value Estimate

Key Insights The projected fair value for GoodRx Holdings is US$11.12 based on 2 Stage Free Cash Flow to Equity Current share price of US$6.46 suggests GoodRx Holdings is potentially 42% undervalued Analyst price target for GDRX is US$6.9... Full story

Yahoo Finance • last year

GoodRx to Participate in the Evercore ISI HealthCONx Conference

SANTA MONICA, Calif., November 16, 2023--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading resource for healthcare savings and information, today announced that executives from the Company will participate in a fireside chat... Full story

Yahoo Finance • last year

GoodRx Reports Third Quarter 2023 Results

SANTA MONICA, Calif., November 09, 2023--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), a leading resource for healthcare savings and information, has released its financial results for the third quarter... Full story

Yahoo Finance • last year

GoodRx Announces Date for Third Quarter 2023 Earnings Release and Conference Call

SANTA MONICA, Calif., October 12, 2023--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), a leading resource for healthcare savings and information, today announced it will release its third quarter 2023 fi... Full story

Yahoo Finance • last year

15 Highest Paying Countries for Pharmacists

In this article, we will look at the 15 highest-paying countries for pharmacists. We have also analyzed the pharmacy industry along with its key market players. If you want to skip our detailed analysis, head straight to the 5Highest Payin... Full story

Yahoo Finance • last year

40% More Savings on Nearly 200 Medications at Walgreens with GoodRX

If you’re struggling to afford prescriptions, GoodRx’s deal with Walgreens could help. Prices on nearly 200 medications will be cut by an average of 40%, and many can be bought for under $15 for a 30-day fill. If you're one of the many Am... Full story

Yahoo Finance • 2 years ago

11 Best Medical  Stocks Under $10

In this piece, we will take a look at the eleven best medical stocks under $10. If you want to skip our analysis of the medical industry and recent trends, head on over to 5 Best Medical  Stocks Under $10. The medical industry is one of t... Full story

Yahoo Finance • 2 years ago

GoodRx (GDRX) Q1 2023 Earnings Call Transcript

Ladies and gentlemen, thank you for standing by and welcome to the GoodRx first quarter 2023 earnings call. Joining me today are Doug Hirsch, our chief mission officer; Trevor Bezdek, our chairman; Karsten Voermann, our chief financial off... Full story

Yahoo Finance • 2 years ago

Why indie pharmacies, with the help of the likes of Mark Cuban, may be on the rise

Independent pharmacies have lost a lot of market share over time. But that trend has recently reversed slightly, making them attractive prospects for large pharmacy benefit managers like Cigna's (CI) Express Scripts, as well as startup dis... Full story

Yahoo Finance • 2 years ago

Is Now The Time To Look At Buying GoodRx Holdings, Inc. (NASDAQ:GDRX)?

GoodRx Holdings, Inc. (NASDAQ:GDRX), is not the largest company out there, but it led the NASDAQGS gainers with a relatively large price hike in the past couple of weeks. With many analysts covering the mid-cap stock, we may expect any pri... Full story

Yahoo Finance • 2 years ago

GoodRx (GDRX) Q4 2022 Earnings Call Transcript

Joining me today are Doug Hirsch and Trevor Bezdek, our co-founders and co-chief executive officers; and Karsten Voermann, our chief financial officer. Before we begin, I'd like to remind everyone that this call will contain forward-lookin... Full story

Yahoo Finance • 2 years ago

GoodRx Shared Personal Health Data With Advertisers, FTC Alleges in Settlement

GoodRx will be prohibited from disclosing consumer health information to third parties for advertising purposes and will pay a $1.5 million civil penalty, under the proposed settlement. Continue reading... Full story

Yahoo Finance • 2 years ago

Novavax, GoodRx stocks on the move after earnings

Yahoo Finance's Anjalee Khemlani breaks down quarterly earnings for Novavax and GoodRx as well as how the market is reacting.... Full story

Yahoo Finance • 2 years ago

10 Best Medical Stocks Under $10

In this article, we will discuss the 10 best medical stocks under $10. To skip our detailed analysis of the healthcare sector, go directly to the 5 Best Medical Stocks Under $10. According to the Centers for Medicare and Medicaid Services... Full story

Yahoo Finance • 2 years ago

Bragar Eagel & Squire, P.C. Is Investigating TG Therapeutics, Allianz, GoodRx, and the WWE and Encourages Investors to Contact the Firm

NEW YORK, July 15, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against TG Therapeutics, Inc. (NASDAQ: TGTX), Allianz SE (OTCMKTS: ALIZY), Go... Full story

Yahoo Finance • 2 years ago

Bragar Eagel & Squire, P.C. Is Investigating Allianz, TrueBlue, and GoodRx and Encourages Investors to Contact the Firm

NEW YORK, July 10, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Allianz SE (OTCMKTS: ALIZY) TrueBlue, Inc. (NYSE: TBI), and GoodRx Ho... Full story

Yahoo Finance • 2 years ago

Bragar Eagel & Squire, P.C. Is Investigating GoodRx, the WWE, Digital World, and Generac and Encourages Investors to Contact the Firm

NEW YORK, July 04, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against GoodRx Holdings, Inc. (NASDAQ: GDRX), World Wrestling Entertainment,... Full story

Yahoo Finance • 2 years ago

Bragar Eagel & Squire, P.C. Is Investigating TrueBlue, NeoGenomics, GoodRx, and Ebix and Encourages Investors to Contact the Firm

NEW YORK, June 29, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against TrueBlue, Inc. (NYSE: TBI), NeoGenomics, Inc. (NASDAQ: NEO), GoodRx H... Full story

Yahoo Finance • 2 years ago

Bragar Eagel & Squire, P.C. Is Investigating GoodRx, Cassava, Ebix, and the WWE and Encourages Investors to Contact the Firm

NEW YORK, June 24, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against GoodRx Holdings, Inc. (NASDAQ: GDRX), Cassava Sciences, Inc. (NASDAQ:... Full story